Cargando…
Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”
Autores principales: | Ward, Lucas D., Moffat, Graeme J., Yuan, Jing, Nioi, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182455/ https://www.ncbi.nlm.nih.gov/pubmed/30066314 http://dx.doi.org/10.1007/s40264-018-0702-y |
Ejemplares similares
-
Naturally Occurring PCSK9 Inhibitors
por: Adorni, Maria Pia, et al.
Publicado: (2020) -
Safety and Tolerability of PCSK9 Inhibitors: Current Insights
por: Kosmas, Constantine E, et al.
Publicado: (2020) -
Berberine: Ins and outs of a nature-made PCSK9 inhibitor
por: Ataei, Sarina, et al.
Publicado: (2022) -
FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017) -
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
por: Rosenson, Robert S., et al.
Publicado: (2016)